N

Neoleukin Therapeutics (NGNE)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Neoleukin Therapeutics (NGNE)

Neoleukin Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. The Company's lead product candidate, NL-201, is an i... Read more

Open
USD19.51
High
USD20.62
Low
USD19.51
52 Week High
USD74.49
Monthly Return
27.40%
Revenue
1M

Daily Vol.
112.72k
Avg. Daily Vol.
193.41k
Market Cap.
311M
52 Week Low
6.88
Annual Return
-52.90%

Stock News

United Natural Foods: Temporary Setback, Long-Term Opportunity

United Natural Foods: Temporary Setback, Long-Term Opportunity

SeekingAlpha

Why IONQ, RGTI and QBTS are Worth the Risk in Quantum Computing

Why IONQ, RGTI and QBTS are Worth the Risk in Quantum Computing

Yahoo

Arbe Robotics: I See The Vision, But Not The Business

Arbe Robotics: I See The Vision, But Not The Business

SeekingAlpha

'Functional freeze' could be the reason even successful people struggle to get out of bed some days: Here's what it means

'Functional freeze' could be the reason even successful people struggle to get out of bed some days: Here's what it means

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.